platelet rich plasma and topical minoxidil(5 percent) fortified with finasteride( 0.1 percent) in the treatment of androgenic alopecia in male patients

A study to compare the efficacy and safety of platelet rich plasma and topical minoxidil(5 percent) fortified with finasteride( 0.1 percent) in the treatment of androgenic alopecia in male patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021467

Enrollment

Registered

2019-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L648- Other androgenic alopecia

Interventions

Intervention1: platelet rich plasma: intradermal injections of platelet rich plasma using a 30 gauze insulin syringe 1cm apart in interfollicular areas at 0,1,2,3 and 6 and 12 months. Control Interve

Eligibility

Inclusion criteria

Inclusion criteria: age 20 to 40 years,androgenic alopecia grade between 2-4 of norwood hamilton scale,platelets equal to or more than 1.5 lacs per microlitre,

Exclusion criteria

Exclusion criteria: dermatological diseases of scalp other than androgenic alopecia,patients with unrealistic expectations from treatment,patirnts with tendency of keloidal formation,patients with hematological or coagulation disorders, patients who are immunosupressed.

Design outcomes

Primary

Measure	Time frame
clinical photographs taken at each visit,investigator assessment scale,patients self assessment scaleTimepoint: every month for 1 year	—

Secondary

Measure	Time frame
various aspects related to sideffects.Timepoint: at every month for 1 year.	—

Countries

India

Contacts

Public ContactDr Prof KS Mehta

DR RPGMC TANDA ,KANGRA,176001

drkaranindermehta@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026